Patent application number | Description | Published |
20080260756 | Peptide Inhibitors of iASPP - The invention relates to a polypeptide or part thereof which inhibits the apoptotic activity of the tumor suppressor protein p53, and includes screening methods to identify agents which interfere with the activity of the polypeptide. | 10-23-2008 |
20080262011 | Modulator - The present invention relates to a compound of formula I, or a pharmaceutically acceptable salt thereof. Formula (I), wherein R | 10-23-2008 |
20100022525 | Arginine Derivatives with NP-I Antagonistic Activity - The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists. | 01-28-2010 |
20100144876 | MODULATOR - The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein Z is OR | 06-10-2010 |
20120077863 | GUANIDINO-SUBSTITUTED BI-AND POLYPHENYLS AS SMALL MOLECULE CARRIERS - A compound of formula I, or a pharmaceutically acceptable salt thereof, wherein —X | 03-29-2012 |
20120122862 | ARGININE DERIVATIVES WITH NP-I ANTAGONISTIC ACTIVITY - The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists. | 05-17-2012 |
20120157385 | CYCLOSPORIN CONJUGATES - A conjugate which comprises a cyclosporin moiety of formula (I) linked to one or more mitochondrial targeting groups, or a pharmaceutically acceptable salt thereof: wherein: A represents or, B represents methyl or ethyl, one Of R | 06-21-2012 |
20120201749 | NP-1 Antagonists and Their Therapeutic Use - Compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein: W is arylene, heteroarylene or formula (a) each L is independently alkylene, alkenylene, alkynylene, a direct bond, arylene, cycloalkylene, alkylene-arylene, alkylene-C═O or —C═O; each X is independently an N-containing heteroarylene, N-containing cycloalkylene or NR; Y is N-containing heteroaryl, N-containing cycloalkyl, NR | 08-09-2012 |
20120269864 | Arginine Derivatives with NP-I Antagonistic Activity - The present invention is a compound of formula (I) or formula (II) which are suitable as NP-1 antagonists. | 10-25-2012 |
20120283295 | INDAZOLE DERIVATIVES AND THEIR USE FOR BLOCKADING VOLTAGE DEPENDENT SODIUM CHANNELS - The invention provides an indazole derivative of formula (1), or a pharmaceutically acceptable salt or N-oxide thereof, wherein R | 11-08-2012 |
20130123356 | MODULATOR - The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof, | 05-16-2013 |
20140357569 | CYCLOSPORIN CONJUGATES - A conjugate which comprises a cyclosporin moiety of formula (I) linked to one or more mitochondrial targeting groups, or a pharmaceutically acceptable salt thereof: wherein: A represents or, B represents methyl or ethyl, one Of R | 12-04-2014 |